Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04331704 · ClinicalTrials.gov registry record · Phase 4
ANCHORS Alcohol & Sexual Health Study: UH3 Project
A Phase 4 study of Substance Use and Alcohol Use, Unspecified, sponsored by University of Florida.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 88
- Enrollment target
- 1
- Study location
NCT04331704 is a Phase 4 study of Substance Use and Alcohol Use, Unspecified that is actively recruiting participants, run by University of Florida. The registered enrollment target is 88 participants, below the 1,259-participant average among 88 other Substance Use trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04331704, a Phase 4 study of Substance Use and Alcohol Use, Unspecified, is actively recruiting participants, sponsored by University of Florida.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 88 participants
- Enrollment target
- 1
- Study location
Study Summary
80 young adult men will complete an initial survey and receive 1 of 2 types of alcohol and sexual health education and information to encourage prevention of alcohol-related problems, HIV and other sexually transmitted infections (STIs). Participants will then take pre-exposure prophylaxis (PrEP) for HIV prevention and complete a daily 5-minute, telephone-based interactive voice response (IVR) assessment of alcohol/substance use, sexual behavior and PrEP taking for 30 days. Medication will all be active PrEP. There is no placebo control in this study. Follow-up will occur after 30-days and 6-months later.
Conditions Studied
Interventions
- DRUG PrEP acronym (pre-exposure prophylaxis)
- BEHAVIORAL Initial Web Survey
- BEHAVIORAL Interactive Voice Response (IVR) monitoring
- BEHAVIORAL Educational material on alcohol and sexual health behavior
- BEHAVIORAL Interactive Voice Response (IVR) assessment with personalized information
Study Locations (1)
Florida
- University of Florida - Gainesville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 88 participants |
| Start Date | 2021-01-12 |
| Est. Completion | 2026-06-30 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04331704
The ClinicalTrials.gov registry entry for NCT04331704 describes a study currently listed as recruiting, categorized as Phase 4. The registered enrollment target is 88 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,259-participant average among 88 other Substance Use trials with a reported enrollment target (93% lower). The listed sponsor is University of Florida, which has 1,106 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Substance Use appearing as the primary indexed condition, and to 5 interventions - of which PrEP acronym (pre-exposure prophylaxis) is the first listed.
NCT04331704 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.
Frequently Asked Questions
What is clinical trial NCT04331704 about?
NCT04331704 is a clinical study titled "ANCHORS Alcohol & Sexual Health Study: UH3 Project". 80 young adult men will complete an initial survey and receive 1 of 2 types of alcohol and sexual health education and information to encourage prevention of alcohol-related problems, HIV and other sexually transmitted infections (STIs). Participants will then take pre-exposure prophylaxis (PrEP) fo...
What is the current status of trial NCT04331704?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 88 participants. The study started on 2021-01-12. Estimated completion is 2026-06-30.
What conditions does trial NCT04331704 study?
This clinical trial studies the following conditions: Substance Use, Alcohol Use, Unspecified, Sex Behavior.
What interventions are being tested in trial NCT04331704?
The interventions under investigation include: PrEP acronym (pre-exposure prophylaxis) (DRUG), Initial Web Survey (BEHAVIORAL), Interactive Voice Response (IVR) monitoring (BEHAVIORAL), Educational material on alcohol and sexual health behavior (BEHAVIORAL), Interactive Voice Response (IVR) assessment with personalized information (BEHAVIORAL).
Who is sponsoring clinical trial NCT04331704?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04331704 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Substance Use
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Native Spirit: Significant Aim 3: Intervention
RECRUITING · NA
-
Parent SMART (Substance Misuse in Adolescents in Residential Treatment)
RECRUITING · NA
-
Cultural Adaptation of Drug Treatment for DJJ Youth
RECRUITING · NA
-
Adaptation and Evaluation of Bright Horizons
RECRUITING · NA
-
Teen Health Choices & Wellness
RECRUITING · NA
-
Pre-exposure Prophylaxis (PrEP) Uptake and Adherence Intervention for Women with Trauma-related Conditions
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.